| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 203 companies in the Health Care Equipment & Supplies industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 10, 2023 | WRBY Warby Parker Inc. | Gilboa David Abraham62 | Co-chief Executive Officer | Sell | 6,517 | $11.04 | $71,947.68 | -96.5% | +8.7% | +10.1% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Scanlan Sean F.65 | Chief Innovation Officer | Sell | 505 | $24.41 | $12,327.05 | -5.1% | +6.0% | -47.0% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Elder Scot Michael | *see "remarks" | Sell | 177 | $24.41 | $4,320.57 | -0.8% | +6.0% | -47.0% | |
| Mar 9, 2023 | RBOT Vicarious Surgical Inc. | Liang Philip45 | Director | Buy | 37,100 | $2.50 | $92,623.86 | +11.6% | -5.3% | -85.5% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Treace John T.60 | Chief Executive Offer | Sell | 2,075 | $24.41 | $50,650.75 | - | +6.0% | -47.0% | |
| Mar 9, 2023 | COO Cooper Companies, Inc. | Warner Gerard H III | President, Coopervision, Inc. | Sell | 1,216 | $340.53 | $414,087.40 | -48.5% | +4.8% | +21.3% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Owens Daniel E.52 | Chief Human Resources Officer | Sell | 411 | $24.41 | $10,032.51 | -3.8% | +6.0% | -47.0% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Hair Mark46 | Chief Financial Officer | Sell | 1,040 | $24.41 | $25,386.40 | -3.7% | +6.0% | -47.0% | |
| Mar 9, 2023 | PODD Insulet Corp | Alpuche Charles64 | Advisor | Sell | 4,000 | $290.90 | $1,163,600.00 | -8.1% | -1.5% | -36.6% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Berutti Aaron | Sr. VP, Sales | Sell | 733 | $24.41 | $17,892.53 | -5.3% | +6.0% | -47.0% | |
| Mar 9, 2023 | ELUT Elutia Inc. | Englese Thomas | Chief Commercial Officer | Sell | 289 | $4.30 | $1,242.70 | -1.6% | -42.3% | -21.2% | |
| Mar 9, 2023 | TMCI Treace Medical Concepts, Inc. | Mott Richard W81 | Director | Sell | 46,502 | $23.26 | $1,081,554.00 | -1.4% | +6.0% | -47.0% | |
| Mar 8, 2023 | MMSI Merit Medical Systems Inc | Ward Lynne48 | Director | Sell | 11,585 | $66.71 | $772,789.01 | -66.0% | +26.5% | +12.9% | |
| Mar 8, 2023 | EW Edwards Lifesciences Corp | Lemercier Jean-Luc M67 | Cvp, Emeacla And Japac | Sell | 6,640 | $76.96 | $510,996.38 | -1.9% | +10.2% | +21.4% | |
| Mar 8, 2023 | ATEC Alphatec Holdings, Inc. | Tullis James L L73 | Director | Sell | 30,000 | $16.12 | $483,600.00 | -6.0% | -3.5% | -18.9% | |
| Mar 8, 2023 | XAIR Beyond Air, Inc. | Carey Robert | Director | Buy | 10,000 | $5.95 | $59,500.00 | +1.2% | -7.0% | -71.5% | |
| Mar 8, 2023 | EW Edwards Lifesciences Corp | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sell | 6,725 | $76.96 | $517,558.02 | -9.7% | +10.2% | +21.4% | |
| Mar 8, 2023 | PRCT Procept Biorobotics Corp | Waters Kevin | EVP, CFO | Sell | 30,000 | $34.33 | $1,030,009.41 | -13.4% | -1.8% | +44.3% | |
| Mar 8, 2023 | XAIR Beyond Air, Inc. | Lisi Steven A.50 | CEO And Chairman Of The Board | Buy | 50,000 | $5.97 | $298,355.00 | +1.8% | -7.0% | -71.5% | |
| Mar 8, 2023 | ATEC Alphatec Holdings, Inc. | Miles Patrick53 | CEO | Sell | 180,000 | $10.56 | $1,901,400.00 | -1.0% | -3.5% | -18.9% | |
| Mar 7, 2023 | COO Cooper Companies, Inc. | Weiss Robert S55 | Director | Sell | 37,510 | $337.72 | $12,667,880.20 | -4.5% | +5.1% | +21.2% | |
| Mar 7, 2023 | BLFS Biolife Solutions Inc | Wichterman Troy60 | Chief Financial Officer | Sell | 31 | $22.95 | $711.45 | - | +4.3% | -22.8% | |
| Mar 7, 2023 | WRBY Warby Parker Inc. | Briggs Teresa63 | Director | Sell | 18,900 | $12.05 | $227,799.81 | -49.5% | -1.1% | +0.5% | |
| Mar 7, 2023 | BLFS Biolife Solutions Inc | Rice Michael72 | CEO | Sell | 549 | $22.95 | $12,599.55 | -0.1% | +4.3% | -22.8% | |
| Mar 7, 2023 | STIM Neuronetics, Inc. | MacAn William Andrew66 | EVP, GC, CCO And Cs | Sell | 12,692 | $4.59 | $58,256.28 | -3.2% | -39.0% | -4.5% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.